EUVIMEDObjevte EUVIMED
Open access · CC BY 4.0

Targeting Ferroptosis: Acteoside as a Neuroprotective Agent in Salsolinol-Induced Parkinson’s Disease Models

Hongquan Wang, Shuang Wu, Qiang Li, Huiyan Sun, Yumin Wang

Frontiers in Bioscience-Landmark · 2025

DOI: 10.31083/fbl26679 ↗

At a glance

Journal article in Frontiers in Bioscience-Landmark, 2025. Written by Hongquan Wang and 4 co-authors. Institution: Department of Geriatrics, Aerospace Center Hospital, Peking University Aerospace School of Clinical Medicine, 100049 Beijing, China. Major MEDLINE topics: Ferroptosis, Neuroprotective Agents, Glucosides, Isoquinolines. Cited 12 times so far (Crossref); 53 references. The full text is freely available (open access, CC BY 4.0). Funded by: Science Foundation of AMHT, The scientific research fund of aerospace center hospital, Natural Science Foundation of Inner Mongolia Autonomous Region (IMAR).

AbstraktSubjectsBibliografické údajeCiteRelated studies

Abstract (original language)

Background

Salsolinol (SAL) is a dopamine metabolite and endogenous neurotoxin that exerts neurotoxicity to dopaminergic neurons and is involved in the genesis of Parkinson’s disease (PD). However, the machinery underlying SAL-induced neurotoxicity in PD is still being elucidated.

Methods

In the present study, we first used RNA-seq and KEGG analysis to examine differentially expressed genes in SAL-challenged SH-SY5Y cells. PD animal models were established and treated with acteoside. Cell viability assays, lipid peroxidation assessments (malondialdehyde [MDA] and 4-Hydroxynonenal [4-HNE]), immunoblot, and transmission electron microscopy were used to confirm acteoside-mediated inhibition of ferroptosis and its neuroprotective effect on dopaminergic (DA) neurons.

Results

We found that ferroptosis-related pathway was enriched by SAL. SAL inducing ferroptosis through upregulating long-chain acyl-CoA synthetase family member 4 (ACSL4) in SH-SY5Y cells, which neurotoxic effect was reversed by ferroptosis inhibitors ferrostatin-1 (Fer-1) and deferoxamine (DFO). Acteoside, a phenylethanoid glycoside of plant origin with a neuroprotective effect, attenuates SAL-induced neurotoxicity by inhibiting ferroptosis in in vitro and in vivo PD models through downregulating ACSL4.

Conclusions

The present study revealed a novel molecular mechanism underlying SAL-induced neurotoxicity via induction of ferroptosis in PD, and uncovered a new pharmacological effect against PD through inhibiting ferroptosis. This study highlights SAL-induced neurotoxicity via ferroptosis as a potential therapeutic target in PD.

Subjects

MeSH terms (MEDLINE)

FerroptosisNeuroprotective AgentsGlucosidesIsoquinolinesParkinson DiseaseAnimalsHumansDisease Models, AnimalMiceDopaminergic NeuronsCell Line, TumorMaleCell SurvivalLipid PeroxidationPolyphenols

Author keywords

Parkinson’s diseaseacteosideferroptosisneuroprotectionsalsolinol

Substances

salsolinolNeuroprotective AgentsGlucosidesIsoquinolinesacteosidePolyphenols

Authors and institutions

  • Department of Geriatrics, Aerospace Center Hospital, Peking University Aerospace School of Clinical Medicine, 100049 Beijing, China.
  • Department of Neurology, Zhongnan Hospital of Wuhan University, 430000 Wuhan, Hubei, China.
  • Department of Neurology, The Affiliated Hospital of Chifeng University, 024005 Chifeng, Inner Mongolia, China.
  • Chifeng University Health Science Center, 024000 Chifeng, Inner Mongolia, China.
  • Department of Respiratory and Critical Care Medicine, Aerospace Center Hospital, Peking University Aerospace School of Clinical Medicine, 100049 Beijing, China.

Funding

  • Science Foundation of AMHT
  • The scientific research fund of aerospace center hospital
  • Natural Science Foundation of Inner Mongolia Autonomous Region (IMAR)
  • Science Foundation of Universities of IMAR
  • Science Foundation of Inner Mongolia Key Laboratory of human genetic diseases
  • Master's Student Science Innovation Project of IMAR
  • Foundation of Inner Mongolia Minzu University
  • Master’s Student Science Innovation Project of IMAR

Cite

APA

Wang, H., Wu, S., Li, Q., Sun, H., & Wang, Y. (2025). Targeting Ferroptosis: Acteoside as a Neuroprotective Agent in Salsolinol-Induced Parkinson’s Disease Models. Frontiers in Bioscience-Landmark. https://doi.org/10.31083/fbl26679

Vancouver

Wang H, Wu S, Li Q, Sun H, Wang Y. Targeting Ferroptosis: Acteoside as a Neuroprotective Agent in Salsolinol-Induced Parkinson’s Disease Models. Frontiers in Bioscience-Landmark. 2025. doi:10.31083/fbl26679

BibTeX
@article{Wang2025,
  author = {Wang, Hongquan and Wu, Shuang and Li, Qiang and Sun, Huiyan and Wang, Yumin},
  title = {Targeting Ferroptosis: Acteoside as a Neuroprotective Agent in Salsolinol-Induced Parkinson’s Disease Models},
  journal = {Frontiers in Bioscience-Landmark},
  year = {2025},
  doi = {10.31083/fbl26679}
}
Start for free →